secwatch.observer — SEC 8-K summary
======================================

Issuer:     MetaVia Inc. (MTVA)
CIK:        0001638287
Form:       8-K
Filed at:   2025-12-02T23:59:59+00:00
Accession:  0001104659-25-117540
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 3.03, 5.03, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MetaVia announces 1-for-11 reverse stock split effective Dec 4, 2025 to meet Nasdaq listing requirements
--------------------------------------------------------------------------------

- Reverse split at 1-for-11 ratio effective 5:00 p.m. ET Dec 4, 2025; begins split-adjusted trading Dec 5.
- Outstanding shares reduced from ~25.4 million to ~2.3 million; authorized shares unchanged at 100 million.
- Options, RSUs, and warrants adjusted proportionately; fractional shares rounded down for cash payment.
- Approved by stockholders on June 30, 2025; board set ratio; new CUSIP 64132R 503; symbol remains MTVA.
- MetaVia is a clinical-stage biotech focused on cardiometabolic diseases; no financial results reported.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1638287/000110465925117540/0001104659-25-117540-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1638287/000110465925117540/mtva-20251202x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-117540

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer